OakChart

Cytosorbents Corp

CTSOHealthcare·Medical Devices·USA·Nano·NASD·Nov 11 • 3:04 PM ET

5.65-0.15 (-2.58%)
2026-11-11 21:06 CET
Market cap
18.28 USD m
Revenue, TTM
37.22 USD m
Net income, TTM
-18.21 USD m
Free cash flow, TTM
-9.30 USD m
EPS diluted, TTM
-5.80
P/E
-
Compare

Price

CTSO against its 20, 50 and 200-day averages
2050200missearnings
5.0010.0015.00342K685KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CTSOclose 5.6520-day 4.8750-day 4.97200-day 9.155.6552w low

66.8% under the 52-week high of 17.00 on 24 Nov 2025. 52-week low 2.84 on 15 Oct 2026. Last 15 sessions, 85.1% high to low

Volume 0.66× normal · the line is the 50-bar volume average

Profile

CTSO
52-week range, 20% of the way up
2.8417.00

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.

Employees129
IPOAug 08, 2006
Beta1.43
ATR, 14d0.71
Rel volume0.66
Short float4.98%
Insider own13.98%
Inst own23.50%

Snapshot

6 groups

Valuation

Index-
Market Cap17.81M
Enterprise Value43.38M
Income-18.21M
Sales37.22M
Book/sh-0.24
Cash/sh1.40
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees129
IPOAug 08, 2006

Ratios

P/E-
Forward P/E-
PEG-
P/S0.48
P/B-
P/C4.04
P/FCF-
EV/EBITDA-
EV/Sales1.17
Quick Ratio0.50
Current Ratio0.66
Debt/Eq-
LT Debt/Eq-
Option/ShortNo / Yes

Earnings

EPS (ttm)-5.80
EPS next Y-0.68
EPS next Q-0.90
EPS this Y-72.18%
EPS next Y84.74%
EPS next 5Y-
EPS past 3/5Y44.07% 8.18%
Sales past 3/5Y2.23% -2.00%
EPS Y/Y TTM-61.01%
Sales Y/Y TTM8.64%
EPS Q/Q-342.60%
Sales Q/Q0.17%
EarningsNov 12 AMC
EPS/Sales Surpr.-55.56% 2.64%

Ownership

Insider Own13.98%
Insider Trans129.36%
Inst Own23.50%
Inst Trans0.09%
ROA-42.38%
ROE-336.19%
ROIC-130.68%
Gross Margin71.61%
Oper. Margin-31.60%
Profit Margin-48.94%
SMA2015.93%
SMA5013.68%
SMA200-38.22%
Trades-

Technical

Shs Outstand3.14M
Shs Float2.71M
Short Float4.98%
Short Ratio3.84
Short Interest0.13M
52W High17.00 -66.76%
52W Low2.84 98.95%
Volatility15.98% 18.75%
ATR (14)0.71
RSI (14)58.45
Beta1.43
Rel Volume0.66
Avg Volume35.10K
Volume20,156

Performance

Perf Week23.91%
Perf Month63.31%
Perf Quarter-22.02%
Perf Half Y-50.49%
Perf YTD-55.80%
Perf Year-59.52%
Perf 3Y-77.75%
Perf 5Y-95.44%
Perf 10Y-94.86%
Recom2.50
Target Price34.83
Prev Close5.80
Price5.65
Change %-2.58%

Analyst ratings

latest 10 of 13
DateActionAnalystRating changeTargetImplied
Sep 07, 2023InitiatedRB. Riley SecuritiesBuy$4-29.2%
Oct 14, 2021ResumedRB. Riley SecuritiesBuy$10+77.0%
Sep 17, 2020InitiatedJJefferiesBuy$15+165.5%
Sep 01, 2020InitiatedSSVB LeerinkOutperform$15+165.5%
Aug 08, 2017ReiteratedMMaxim GroupBuy$10 → $12+112.4%
Oct 26, 2016InitiatedAAegis CapitalBuy
May 24, 2016InitiatedMMaxim GroupBuy$8+41.6%
Oct 29, 2015UpgradeWWBB SecuritiesSpeculative Buy → Buy$13 → $13+130.1%
May 12, 2015ReiteratedMMLV & CoBuy$28 → $21+271.6%
Apr 01, 2015ReiteratedMMLV & CoBuy$28 → $30+430.9%

Peers

Mkt cap
TickerCompanyMkt cap
AEMDAethlon Medical Inc9.08M
NUWENuwellis Inc2.99M
CERSCerus Corp424.10M
OMOutset Medical Inc80.12M
BJDXBluejay Diagnostics Inc3.01M
HAEHaemonetics Corp5.50B
NEPHNephros Inc33.91M
RMTIRockwell Medical Inc28.29M
DXRDaxor Corp49.87M
BAXBaxter International Inc13.62B

Insider trading

7 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Chan Phillip P.Chief Executive OfficerSep 15 '26Buy6.003,77422,644100,996Sep 16 05:30 PM
Capponi VincentPresident and COOSep 14 '26Buy6.052,07312,53740,387Sep 16 04:05 PM
Sobel Alan D.DirectorSep 15 '26Buy6.102,50015,2549,887Sep 16 04:05 PM
Chan Phillip P.Chief Executive OfficerSep 04 '26Buy0.35200,00070,0001,944,432Sep 09 04:05 PM
MARIANI PETER JChief Financial OfficerJun 15 '26Buy0.44100,00044,000638,113Jun 16 07:00 AM
Chan Phillip P.Chief Executive OfficerJun 12 '26Buy0.40251,136100,4541,734,099Jun 15 06:24 PM
Chan Phillip P.Chief Executive OfficerJun 15 '26Buy0.4310,3334,4431,744,432Jun 15 06:24 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
MSSMMorgan Stanley Pathway Small-Mid Cap Equity ETFAUM: 705.72M

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-12--0.900--9.903
2026Q22026-08-06-1.400-0.900-1.4009.639.392
2026Q12026-05-13-1.600-1.000-1.6358.869.401
2025Q42026-03-25-1.800-1.100-1.7519.239.782
2025Q32025-11-13-0.800-0.800-1.0109.4910.402
2025Q22025-08-070.600-1.0000.5809.629.402
2025Q12025-05-14-1.200-1.300-0.4878.739.212
2024Q42025-03-31-0.600-1.000-2.8829.2010.252
2024Q32024-11-07-1.600-1.100-0.8579.3910.362
2024Q22024-08-13-1.600-1.950-1.5269.909.684
2024Q12024-05-09-2.400-2.400-2.3439.799.803
2023Q42024-03-14-2.400-2.750-2.4008.709.284
2023Q32023-11-09-4.200-2.466-4.1448.819.506
2023Q22023-08-01-2.800-2.264-2.7969.4211.034
2023Q12023-05-02-3.400-2.534-3.3559.458.743
2022Q42023-03-09-0.200-3.500-0.3529.408.544

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-12.000-12.240-11.94624.9524.36
2020FY-4.000-4.626-4.03841.0140.80
2021FY-11.400-8.780-11.32843.1742.08
2022FY-15.000-17.800-15.06134.6933.78
2023FY-12.800-13.200-13.09936.3536.61
2024FY-7.600-5.600-7.61235.6039.29
2025FY-2.600-3.333-2.60037.0637.44
2026FY--4.477--38.73
2027FY--0.683--43.40
2028FY-0.600--51.60
2029FY-0.800--54.39
2030FY-14.400--133.04

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-10-232009.909.7010.10
2026Q3S2026-08-142019.909.7010.10
2026Q3S2026-08-0710010.1010.1010.10
2026Q3S2026-07-2810010.1710.1710.17
2026Q3S2026-07-1110110.1710.1710.17
2026Q3S2026-06-1620110.039.9010.17
2026Q3S2026-05-2120210.039.9010.17
2026Q3S2026-05-2030310.109.9010.24
2026Q3S2026-05-1430310.109.9010.24
2026Q3S2026-04-1920110.259.9010.60
2026Q3S2026-04-0230110.339.9010.60
2026Q3S2026-03-2630010.5310.4910.60
2026Q3S2026-02-2830010.5310.4910.60
2026Q3S2026-01-2830110.5310.4910.60

Estimate history

EPS, annual-6.371-11.205-11.946-4.038-11.328-15.061-13.099-7.612-2.635-5.8024
Period201720182019202020212022202320242025TTM
EPS, quarterly-1.526-0.857-2.882-0.4870.58-1.01-1.751-1.635-1.407
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual15.15122.50424.94941.00543.16634.68931.08535.59537.06337.22
Period201720182019202020212022202320242025TTM
Sales, quarterly9.8959.396.5238.7279.6179.4859.2348.8649.633
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual1.4491.5891.6312.1612.1742.1742.7122.7423.143.142
Period201720182019202020212022202320242025MRQ
Shares, quarterly2.7152.7252.7423.1263.1313.143.143.1373.142
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue37.2237.0635.5931.0834.6943.1741.0024.9522.50
Cost of Goods Sold Incl. D&A10.5710.5710.479.1313.9611.0511.057.367.49
Gross Profit26.6526.4925.1321.9520.7332.1229.9517.5915.01
Selling, General and Administrative Excl. Other38.4140.7341.9153.9051.6254.8640.3236.5630.60
Research and Development4.645.086.9215.5915.1216.388.8112.097.72
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-11.76-14.24-16.79-31.95-30.89-22.74-10.37-18.97-15.58
Interest Expense3.122.611.400.16--1.201.031.46
Unusual Expense1.731.070.330.660.64----
Net Income Before Taxes-18.61-8.60-22.41-30.06-33.91-25.29-8.96-20.36-17.83
Income Taxes-0.40-0.40-1.69-0.81-1.09-0.74-1.13-1.09-0.62
Consolidated Net Income-18.21-8.20-20.72-29.25-32.81-24.56-7.84-19.27-17.21
Net Income From Continuing Operations-18.21-8.20-20.72-29.25-32.81-24.56-7.84-19.27-17.21
Net Income-18.21-8.20-20.72-29.25-32.81-24.56-7.84-19.27-17.21
EPS (Recurring)-5.41-2.39-7.53-12.89-14.86-11.33-4.04-11.95-11.21
EPS (Basic, Before Extraordinaries)-5.80-2.63-7.61-13.10-15.06-11.33-4.04-11.95-11.21
EPS (Diluted)-5.80-2.63-7.61-13.10-15.06-11.33-4.04-11.95-11.21
EBITDA-10.22-12.61-15.04-29.92-29.75-21.62-9.71-18.39-15.19
Non-Operating Income (Expense)-2.019.32-3.892.70-2.38-2.552.61-0.35-0.78
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.002.182.973.282.502.942.571.223.51
Price To Sales Ratio0.631.071.391.591.954.217.554.9811.03
Gross Margin71.6171.4870.5970.6259.7774.4173.0570.4866.72
Operating Margin-31.60-38.42-47.16-102.78-89.04-52.69-25.29-76.05-69.25
Net Margin-48.94-22.12-58.21-94.09-94.59-56.89-19.11-77.22-76.48
Shares Outstanding3.143.142.742.712.172.172.161.631.59
Market Capitalization18.2818.2849.9048.6767.63182.17344.48125.57256.74

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue9.638.869.239.489.628.736.529.39
Cost of Goods Sold Incl. D&A2.582.732.432.822.802.52-4.11
Gross Profit7.056.136.806.676.816.21-5.28
Selling, General and Administrative Excl. Other9.358.8710.869.3310.4310.0912.718.85
Research and Development1.451.021.240.921.261.661.301.85
Other Operating Expense0.000.000.000.000.000.000.000.76
Operating Income-2.30-2.74-4.05-2.66-3.62-3.89-6.62-4.33
Interest Expense0.870.860.750.650.620.610.620.59
Unusual Expense0.330.300.890.200.000.000.020.06
Net Income Before Taxes-4.42-5.13-5.50-3.571.95-1.48-9.57-2.33
Income Taxes0.000.000.00-0.400.000.00-1.690.00
Consolidated Net Income-4.42-5.13-5.50-3.171.95-1.48-7.88-2.33
Net Income From Continuing Operations-4.42-5.13-5.50-3.171.95-1.48-7.88-2.33
Net Income-4.42-5.13-5.50-3.171.95-1.48-7.88-2.33
EPS (Recurring)-1.33-1.57-1.55-0.970.58-0.49-2.88-0.84
EPS (Basic, Before Extraordinaries)-1.41-1.64-1.75-1.010.62-0.49-2.88-0.86
EPS (Diluted)-1.41-1.64-1.75-1.010.58-0.49-2.88-0.86
EBITDA-1.93-2.37-3.67-2.26-3.17-3.48-6.19-3.90
Non-Operating Income (Expense)-0.91-1.230.19-0.066.183.01-4.882.65
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.370.540.700.390.570.820.630.78
Price To Sales Ratio0.630.961.081.712.511.761.402.16
Gross Margin73.1869.1673.6870.2870.8571.13-56.24
Operating Margin-23.92-30.96-43.87-28.07-37.59-44.54-101.46-46.13
Net Margin-45.85-57.86-59.53-33.4220.25-16.94-120.86-24.86
Shares Outstanding3.143.143.143.143.133.132.742.73
Market Capitalization18.2835.5340.1458.6680.1462.5349.9081.75

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments6.258.2814.1322.1452.1471.4212.2322.3717.32
Short Term Receivables7.557.326.065.664.525.164.473.942.21
Inventories5.282.733.383.464.772.672.110.830.80
Other Current Assets1.553.271.832.492.873.202.091.120.42
Total Current Assets20.6321.6025.4033.7664.3082.4520.9028.2620.74
Net Property, Plant & Equipment18.7520.5122.1223.3518.573.153.003.181.40
Total Investments and Advances1.521.481.481.691.690.000.000.000.00
Long-Term Note Receivable---0.050.260.130.120.13-
Intangible Assets3.233.753.914.394.704.223.362.631.84
Deferred Tax Assets3.463.593.71------
Other Assets0.050.020.050.000.000.000.000.000.12
Total Assets47.6450.9656.6663.2389.5289.9527.3834.2024.10
Short Term Debt Incl. Current Port. of LT Debt0.810.452.870.110.570.452.091.054.00
Accounts Payable2.873.343.801.662.811.842.041.491.55
Income Tax Payable--0.060.020.790.900.400.180.18
Other Current Liabilities6.036.037.367.939.536.975.404.202.12
Total Current Liabilities9.719.8214.049.7113.6910.159.946.927.85
Long Term Debt28.5726.4415.4418.1413.250.5814.0310.355.99
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities3.463.593.71------
Other Liabilities0.000.000.000.000.000.000.000.000.00
Total Liabilities41.7439.8533.1827.8626.9410.7323.9617.2613.84
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity5.9011.1123.4835.3762.5879.223.4216.9310.26
Total Shareholders Equity5.9011.1123.4835.3762.5879.223.4216.9310.26
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity5.9011.1123.4835.3762.5879.223.4216.9310.26
Total Liabilities & Stockholders Equity47.6450.9656.6663.2389.5289.9527.3834.2024.10
Book Value Per Share1.884.058.6616.2728.7936.662.1010.667.08
Tangible Book Value Per Share0.852.687.2214.2526.6234.700.039.015.82
Full-Time Employees12914918619822119515312584
Price to Book Ratio-24.274.492.631.732.914.3536.7415.1619.54
Return on Assets-16.63-38.40-48.79-42.96-27.37-13.36-64.08-59.04-50.07
Return on Equity-96.39-120.52-99.38-67.00-34.64-18.97-189.32-126.56-145.87
Return on Invested Capital-23.78-55.18-75.14-61.31-32.39-9.82-110.43-63.09-52.05
Quick Ratio1.581.921.573.124.357.861.893.972.54
Current Ratio2.132.201.813.484.708.122.104.092.64

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-18.21-8.20-20.72-29.25-32.81-24.56-7.84-19.27-17.21
Depreciation1.541.631.742.021.131.130.660.580.39
Other Funds (Non Cash)6.58-4.788.932.927.018.782.323.386.92
Funds from Operations-10.10-11.35-10.05-24.30-24.67-14.65-4.86-15.31-9.90
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital0.95-1.03-4.382.65-3.560.64-0.76-1.45-0.94
Cash from Operating Activities-9.15-12.38-14.43-21.66-28.23-14.01-5.61-16.76-10.84
Capital Expenditures-0.44-0.49-0.67-0.94-6.46-4.28-1.68-1.52-1.52
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.160.080.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.28-0.41-0.67-0.94-6.46-4.28-1.68-1.52-1.52
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.006.830.1814.47-0.040.7281.723.1817.61
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.006.830.1814.47-0.040.7281.723.1817.61
Proceedsfrom Stock Options0.005.390.1814.26-0.04-0.0980.210.6714.13
Issuance or Reduction of Debt, Net2.482.489.300.005.000.00-15.385.00-0.15
Change in Long Term Debt2.482.489.300.005.000.00-15.385.00-0.15
Issuance of Long Term Debt2.482.4814.300.005.000.001.415.000.52
Reduction of Long Term Debt0.000.00-5.000.000.000.00-16.790.00-0.67
Net Financing Active Other Cash Flow0.000.00-0.150.000.000.000.000.000.00
Other Financing Activities Uses0.000.00-0.150.00-0.00--0.00
Cash from Financing Activities2.489.319.3314.474.960.7266.358.1817.47
Exchange Rate Effect1.151.49-0.08-0.10-0.26-0.020.13-0.04-0.06
Net Change in Cash-5.79-1.99-5.85-8.22-29.99-17.6059.19-10.145.05
Free Cash Flow-9.30-12.54-14.71-22.19-34.32-17.65-6.32-17.46-11.51
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments4.414.816.257.5410.2011.59
Short Term Receivables6.797.157.557.437.747.67
Inventories3.694.485.284.003.713.02
Other Current Assets0.851.311.552.351.333.14
Total Current Assets15.7417.7620.6321.3122.9925.41
Net Property, Plant & Equipment17.7818.2818.7519.2719.6920.09
Total Investments and Advances1.521.521.521.521.521.52
Intangible Assets2.862.953.233.593.743.70
Deferred Tax Assets--3.46---
Other Assets0.050.050.050.060.050.05
Total Assets37.9640.5647.6445.7547.9950.78
Short Term Debt Incl. Current Port. of LT Debt15.307.480.810.800.780.73
Accounts Payable2.003.132.873.043.393.33
Other Current Liabilities6.725.696.036.285.675.68
Total Current Liabilities24.0216.309.7110.119.849.74
Long Term Debt14.6922.0728.5726.6226.5626.50
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities--3.46---
Other Liabilities0.000.000.000.000.000.00
Total Liabilities38.7138.3741.7436.7336.4036.24
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-0.752.195.909.0211.5914.54
Total Shareholders Equity-0.752.195.909.0211.5914.54
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity-0.752.195.909.0211.5914.54
Total Liabilities & Stockholders Equity37.9640.5647.6445.7547.9950.78
Book Value Per Share-0.240.701.882.873.704.65
Tangible Book Value Per Share-1.15-0.240.851.732.513.47
Full-Time Employees--129---
Price to Book Ratio-24.2716.196.806.506.924.30
Return on Assets-42.38-25.94-16.63-22.63-19.23-32.37
Return on Equity-336.19-141.59-96.39-96.15-68.84-94.65
Return on Invested Capital-31.69-21.14-15.95-8.895.10-3.60
Quick Ratio0.500.811.581.711.962.30
Current Ratio0.661.092.132.112.342.61

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-4.42-5.13-5.50-3.171.95-1.48
Depreciation0.380.380.390.400.440.40
Other Funds (Non Cash)1.872.341.450.93-5.15-2.00
Funds from Operations-2.18-2.42-3.66-1.84-2.77-3.08
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital1.591.25-1.17-0.731.26-0.39
Cash from Operating Activities-0.58-1.16-4.83-2.58-1.51-3.46
Capital Expenditures-0.05-0.07-0.370.06-0.13-0.05
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.060.030.080.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities0.01-0.05-0.290.06-0.13-0.05
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.00-0.006.83
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.00-0.006.83
Proceedsfrom Stock Options0.000.000.000.00-0.005.39
Issuance or Reduction of Debt, Net0.000.002.480.000.000.00
Change in Long Term Debt0.000.002.480.000.000.00
Issuance of Long Term Debt0.000.002.480.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities0.000.002.480.00-0.006.83
Exchange Rate Effect0.18-0.231.35-0.150.260.03
Net Change in Cash-0.40-1.44-1.29-2.67-1.383.35
Free Cash Flow-0.60-1.17-4.93-2.59-1.55-3.47

Revenue breakdown

Consolidation, Policy2024: 480
Total Surgical & Medical Instruments & Apparatus revenue2025: 37.06M
Total product sales2024: 35.59M
All other countries2024: 22.39M 2025: 25.06M
Germany2024: 13.05M 2025: 11.75M
United States2024: 151.00K 2025: 249.00K

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-304.98%0.1M2.7M33.19K
2026-10-154.22%0.1M2.7M12.87K
2026-09-304.57%0.1M2.7M11.76K
2026-09-154.45%0.1M2.7M12.80K
2026-08-313.66%0.1M3.2M7.77K
2026-08-143.96%0.1M2.7M7.74K
2026-07-314.14%0.1M2.6M7.89K
2026-07-154.09%0.1M2.6M7.86K
2026-06-304.01%0.1M2.6M7.87K
2026-06-154.01%0.1M2.6M6.30K
2026-05-293.96%0.1M2.6M4.63K
2026-05-153.93%0.1M2.6M4.26K
2026-04-303.90%0.1M2.6M4.07K
2026-04-153.90%0.1M2.6M4.39K
2026-03-313.87%0.1M2.6M4.26K
2026-03-133.85%0.1M2.6M4.55K
2026-02-273.82%0.1M2.6M4.75K
2026-02-133.89%0.1M2.6M5.29K
2026-01-303.89%0.1M2.6M5.76K
2026-01-153.79%0.1M2.6M5.75K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-09-238-KCurrent report2026-09-22SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-088-KCurrent report2026-09-08SEC
2026-08-148-KCurrent report2026-08-13SEC
2026-08-078-KCurrent report2026-08-06SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-068-KCurrent report2026-06-29SEC
2026-06-25ARSAnnual report to security holders. 2025-12-31SEC
2026-06-25DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-06-25DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-08-13SEC
2026-06-258-KCurrent report2026-06-24SEC
2026-06-164Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-154Statement of changes in beneficial ownership of securities2026-06-12SEC
2026-06-11PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-11SEC
2026-05-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-138-KCurrent report2026-05-13SEC
2026-04-1510-K/A2025-12-31SEC
2026-04-028-KCurrent report2026-04-01SEC
2026-03-3010-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-03-258-KCurrent report2026-03-25SEC
2026-02-13SCHEDULE 13G/ASEC
2025-11-204Statement of changes in beneficial ownership of securities2025-11-18SEC
2025-11-1310-QQuarterly report pursuant to Section 13 or 15(d)2025-09-30SEC
2025-11-138-KCurrent report2025-11-13SEC
2025-10-038-KCurrent report2025-10-02SEC
2025-09-168-KCurrent report2025-09-16SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-09120.43K400
2026-080000
2026-070000
2026-06148.90K300
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
AVENIR CORP8.26%
Neuberger Berman Group LLC3.13%
VANGUARD CAPITAL MANAGEMENT LLC3.05%
CM Management, LLC2.35%
Skylands Capital, LLC1.25%
BlackRock, Inc.1.00%
GEODE CAPITAL MANAGEMENT, LLC0.96%
Sargent Investment Group, LLC0.88%
Pathstone Holdings, LLC0.80%
VANGUARD FIDUCIARY TRUST CO0.50%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.03%
Neuberger Intrinsic Value Fund1.03%
VANGUARD EXTENDED MARKET INDEX FUND0.91%
Fidelity Extended Market Index Fund0.46%
Fidelity Total Market Index Fund0.15%
Fidelity Series Total Market Index Fund0.13%
VANGUARD BALANCED INDEX FUND0.06%
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND0.05%
Fidelity Nasdaq Composite Index Fund0.04%
Morgan Stanley Pathway Small-Mid Cap Equity ETF0.03%

OakChart. CTSO. Cached 15 minutes.